Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pirofski

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Molecular Medicine|June 28, 2005
Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformansA Casadevall, L Pirofski
The Journal of Infectious Diseases|July 10, 2001
Host-pathogen interactions: the attributes of virulenceA Casadevall, L Pirofski
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2009
Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityM L Ritter, L Pirofski
Current Tropical Medicine Reports|May 29, 2019
Antibody immunity and natural resistance to cryptococcosisN Trevijano-Contador, L Pirofski
Current Pharmaceutical Design|April 8, 2003
Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiersU K Buchwald, L Pirofski
The Journal of Infectious Diseases|November 7, 1998
A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosisR Fleuridor, Z Zhong, L Pirofski
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infectionR Fleuridor, A Lees, L Pirofski
The Journal of Infectious Diseases|October 9, 1999
Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitisR Fleuridor, R H Lyles, L Pirofski
The Journal of Infectious Diseases|April 14, 2000
A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected personsQ Chang, J Abadi, P Alpert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
Cryptococcosis in children with AIDSJ Abadi, S Nachman, A B Kressel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Molecular Medicine|June 28, 2005
Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformansA Casadevall, L Pirofski
The Journal of Infectious Diseases|July 10, 2001
Host-pathogen interactions: the attributes of virulenceA Casadevall, L Pirofski
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2009
Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityM L Ritter, L Pirofski
Current Tropical Medicine Reports|May 29, 2019
Antibody immunity and natural resistance to cryptococcosisN Trevijano-Contador, L Pirofski
Current Pharmaceutical Design|April 8, 2003
Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiersU K Buchwald, L Pirofski
The Journal of Infectious Diseases|November 7, 1998
A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosisR Fleuridor, Z Zhong, L Pirofski
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infectionR Fleuridor, A Lees, L Pirofski
The Journal of Infectious Diseases|October 9, 1999
Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitisR Fleuridor, R H Lyles, L Pirofski
The Journal of Infectious Diseases|April 14, 2000
A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected personsQ Chang, J Abadi, P Alpert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
Cryptococcosis in children with AIDSJ Abadi, S Nachman, A B Kressel, et al.
Pageof 2